Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Udvidet
  • Karyotype is an independent pr...
  • Citér dette
  • Stav dette
  • Email dette
  • Udskriv
  • Eksportér post
    • Eksportér til RefWorks
    • Eksportér til EndNoteWeb
    • Eksportér til EndNote
  • Permanent link
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia

Bibliografiske detaljer
Main Authors: Moorman, A, Harrison, C, Buck, G, Richards, S, Secker-Walker, L, Martineau, M, Vance, G, Cherry, A, Higgins, R, Fielding, A, Foroni, L, Paietta, E, Tallman, MS, Wernik, P, Litzow, MR, Rowe, J, Goldstone, A, Dewald, G
Format: Conference item
Udgivet: 2007
  • Beholdninger
  • Beskrivelse
  • Lignende værker
  • Medarbejdervisning

Lignende værker

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia
    af: Moorman, A, et al.
    Udgivet: (2007)
  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
    af: Moorman, A, et al.
    Udgivet: (2007)
  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
    af: Moorman, A, et al.
    Udgivet: (2005)
  • Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
    af: Fielding, A, et al.
    Udgivet: (2010)
  • Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
    af: Fielding, A, et al.
    Udgivet: (2010)

Søgemuligheder

  • Søg Historie
  • Udvidet søgning

Find flere

  • Gennemse kataloget
  • Gennemse alfabetisk
  • Explore Channels
  • Kursusreservationer
  • Nye værker

Har du brug for hjælp?

  • Søgetips
  • Spørg en bibliotekar
  • FAQ’er